Evidence map›Paper›PMID 25899451›Full record

ArticleDiabetologia2015

Subcutaneous fat transplantation alleviates diet-induced glucose intolerance and inflammation in mice.

Samantha L Hocking, Rebecca L Stewart, Amanda E Brandon, Eurwin Suryana, Ella Stuart, Emily M Baldwin, Ganesh A Kolumam, Zora Modrusan, Jagath R Junutula, Jenny E Gunton and 7 more

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03703141 (Effect of Acute or Chronic Ingestion of Sucralose on Serum Insulin in Young and Healthy Adults), which is not on this map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03703141 nacompletednot on this mapstarted 2016, after this paper: background citation

Effect of Acute or Chronic Ingestion of Sucralose on Serum Insulin in Young and Healthy Adults: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorHospital General de México Dr. Eduardo LiceagaRan2016 to 2018Enrolled95ConditionsHealthyArmssucralose 48 mg (splenda)/day for ten weeks
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 2 countries.

Samantha L HockingDiabetes and Metabolism Division, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, 2010, Sydney, NSW, Australia.
Rebecca L Stewart
Amanda E Brandon
Eurwin Suryana
Ella Stuart
Emily M Baldwin
Ganesh A Kolumam
Zora Modrusan
Jagath R Junutula
Jenny E Gunton
Michael Medynskyj
Sinead P Blaber
Elisabeth Karsten
Benjamin R Herbert
David E James
Gregory J Cooney
Michael M Swarbrick
Garvan Institute of Medical Research · AUAngiogenesis Foundation · USMacquarie University · AUWestmead Institute · AUOlympus (Australia) · AUSt Vincent's Hospital Sydney · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisAdipose tissue (AT) distribution is a major determinant of mortality and morbidity in obesity. In mice, intra-abdominal transplantation of subcutaneous AT (SAT) protects against glucose intolerance and insulin resistance (IR), but the underlying mechanisms are not well understood.

methodsWe investigated changes in adipokines, tissue-specific glucose uptake, gene expression and systemic inflammation in male C57BL6/J mice implanted intra-abdominally with either inguinal SAT or epididymal visceral AT (VAT) and fed a high-fat diet (HFD) for up to 17 weeks.

resultsGlucose tolerance was improved in mice receiving SAT after 6 weeks, and this was not attributable to differences in adiposity, tissue-specific glucose uptake, or plasma leptin or adiponectin concentrations. Instead, SAT transplantation prevented HFD-induced hepatic triacylglycerol accumulation and normalised the expression of hepatic gluconeogenic enzymes. Grafted fat displayed a significant increase in glucose uptake and unexpectedly, an induction of skeletal muscle-specific gene expression. Mice receiving subcutaneous fat also displayed a marked reduction in the plasma concentrations of several proinflammatory cytokines (TNF-α, IL-17, IL-12p70, monocyte chemoattractant protein-1 [MCP-1] and macrophage inflammatory protein-1β [ΜIP-1β]), compared with sham-operated mice. Plasma IL-17 and MIP-1β concentrations were reduced from as early as 4 weeks after transplantation, and differences in plasma TNF-α and IL-17 concentrations predicted glucose tolerance and insulinaemia in the entire cohort of mice (n = 40). In contrast, mice receiving visceral fat transplants were glucose intolerant, with increased hepatic triacylglycerol content and elevated plasma IL-6 concentrations. CONCLUSIONS/

interpretationIntra-abdominal transplantation of subcutaneous fat reverses HFD-induced glucose intolerance, hepatic triacylglycerol accumulation and systemic inflammation in mice.

Indexed as

AdipocytesAdiponectinAdiposityAnimalsBody CompositionCytokinesDiet, High-FatEatingGluconeogenesisGlucoseGlucose IntoleranceInflammationInsulinLeptinLiverMaleAdiponectinCytokinesGlucoseInsulinLeptinTriglycerides

Identifiers

PMID25899451
OpenAlexW1995365816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.